Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
| Image |  |
|---|---|
| Description | scientific article published on 24 April 2019 |
| Author/s |
author: Shengxiang Ren Chao Zhao |
| Publication date | April 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |